Jjp. Kastelein et al., Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women, CLIN GENET, 56(4), 1999, pp. 297-305
Citations number
53
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
We assessed the effect of two common mutations in the lipoprotein lipase ge
ne (LPL), D9N and N291S, which have been shown to modulate plasma lipids in
a wide spectrum of patients.
A total of 1114 men and 1144 women from the Framingham Offspring Study (FOS
) were analyzed for these two LPL variants. Subsequently, the association w
ith fasting plasma lipids and risk of coronary artery disease (CHD) was det
ermined. We extended our study by calculating weighed means of lipids and l
ipoproteins in carriers and non-carriers for these LPL mutations in patient
s with genetic dyslipidemias, CHD patients and healthy controls.
In the FOS sample, the D9N and N291S alleles were associated with lower hig
h-density lipoprotein-cholesterol (HDL-C) (Delta = -0.07 mmol/l, p = 0.03)
and a trend towards increased triglycerides (Delta = 0.25 mmol/l, p = 0.07)
. In women, a trend towards the high triglyceride, low HDL-C phenotype was
evident (Delta = -0.02 mmol/l for HDL-C and Delta = 0.14 mmol/l for triglyc
erides, respectively). Cumulative analysis of other studies of male carrier
s of the D9N and N291S revealed higher levels of triglycerides (D291N; 2.60
(1.85) mmol/l vs. 1.62(1.18) mmol/l: p < 0.0001) (D9N; 1.94 (1.19) mmol/l v
s. 1.74(1.17) mmol/l: p < 0.001) and lower HDL-C (N291S; 1.04(0.32) mmol/l
vs. 1.15(0.28) mmol/l: p < 0.0001) (D9N; 1.08(0.24) mmol/l vs. 1.16(0.28) m
mol/l: p < 0.0001). In females, results differed with higher TG levels (N29
1S; 1.70(0.99) mmol/l vs. 1.10(0.63) mmol/l: p < 0.001) (D9N; 1.08(0.76) mm
ol/l vs. 0.96(0.51) mmol/l: p < 0.01) and lower HDL-C levels (N291S; 1.27(0
.33) mmol/l vs. 1.51(0.32) mmol/l: p < 0.0001); however, the HDL-C levels f
or D9N carriers were similar to non-carriers (D9N; 1.52(0.29) mmol/l vs. 1.
53(0.35) mmol/l: p = 0.83).
Our data provide evidence that common variants of the LPL gene are signific
ant modulators of lipid and lipoprotein levels in both men and women.